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Abstract. 
 
Autophagy is a membrane trafﬁcking to vac-
uole/lysosome induced by nutrient starvation. In 
 
Sac-
charomyces cerevisiae
 
, Tor protein, a phosphatidylinosi-
tol kinase-related kinase, is involved in the repression
of autophagy induction by a largely unknown mecha-
nism. Here, we show that the protein kinase activity of
Apg1 is enhanced by starvation or rapamycin treat-
ment. In addition, we have also found that Apg13,
which binds to and activates Apg1, is hyperphosphory-
lated in a Tor-dependent manner, reducing its afﬁnity to
Apg1. This Apg1–Apg13 association is required for au-
tophagy, but not for the cytoplasm-to-vacuole targeting
(Cvt) pathway, another vesicular transport mechanism
in which factors essential for autophagy (Apg proteins)
are also employed under vegetative growth conditions.
Finally, other Apg1-associating proteins, such as Apg17
and Cvt9, are shown to function speciﬁcally in autoph-
agy or the Cvt pathway, respectively, suggesting that the
Apg1 complex plays an important role in switching be-
tween two distinct vesicular transport systems in a nu-
trient-dependent manner. 
Key words: starvation • Cvt • yeast • rapamycin •
phosphorylation
 
Introduction
 
Cell growth is tightly linked with the cell’s perception of its
nutritional environment. In particular, microorganisms,
such as the yeast 
 
Saccharomyces cerevisiae
 
, that spend
most of their time in the stationary phase in the wild, re-
quire accurate responses to varying nutrient conditions for
their survival. Therefore, yeast is a good model organism
for the study of nutrient detection and response. Autoph-
agy is one of several responses to nutrient starvation
(Klionsky and Ohsumi, 1999). A large number of cyto-
plasmic components are nonselectively enclosed within a
double-membrane structure called an autophagosome, in
which they are transported into the vacuole/lysosome to
be degraded by resident hydrolases. Such turnover of a
large amount of cytoplasm mediated by autophagy is es-
sential for survival under nutrient-depleted conditions.
We have isolated several genes essential for autophagy
(termed 
 
APG
 
) and have been investigating the function of
the gene products (Tsukada and Ohsumi, 1993; Funakoshi
et al., 1997; Matsuura et al., 1997; Mizushima et al., 1998).
Genetic and morphological analyses revealed that the deg-
radative process of autophagy shares mechanistic compo-
nents with the cytoplasm-to-vacuole targeting (Cvt)
 
1
 
 path-
way (Harding et al., 1996; Scott et al., 1996; Baba et al.,
1997), which is biosynthetic, delivering a resident hydro-
lase, aminopeptidase I (API), to the vacuole (Klionsky
and Ohsumi, 1999). On the other hand, autophagy and the
Cvt pathway are distinct in many aspects. The two path-
ways appear to be regulated separately; the Cvt pathway is
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mainly observed under growing conditions, whereas au-
tophagy is induced by starvation (Baba et al., 1997; Klion-
sky and Ohsumi, 1999). Furthermore, Cvt vesicles and au-
tophagosomes, the vesicles formed in the Cvt pathway and
autophagy, respectively, are clearly different in size (Baba
et al., 1997). Recently, the t-SNARE Tlg2 and Sec1-homo-
logue Vps45 were found to be required for the Cvt path-
way, but dispensable for autophagy, suggesting that these
two pathways are mechanistically distinct (Abeliovich et
al., 1999).
Tor is a phosphatidylinositol kinase-related kinase that
promotes cell cycle progression in response to nutrient
availability (Thomas and Hall, 1997). The function of Tor
appears to be conserved from yeast to mammals. Treat-
ment with the immunosuppressant rapamycin, a specific
inhibitor of Tor, induced cell cycle arrest at G
 
0
 
. Rapamy-
cin-induced Tor inhibition also induces several character-
istic phenotypes of starved cells. For example, accumula-
tion of glycogen, repression of genes that are stimulated in
growing cells, and stimulation of genes that are induced
during starvation, all result from inhibition of Tor (Hard-
wick et al., 1999). Rapamycin mimics the starvation re-
sponse even under nutrient rich conditions. Our labora-
tory has found that rapamycin induces autophagy in yeast
(Noda and Ohsumi, 1998). However, the molecular mech-
anism by which Tor negatively regulates autophagy re-
mains to be determined. Here, we present evidence that
Apg1, a protein kinase essential for autophagy, plays a
pivotal role in induction of Tor-regulated autophagy.
 
Materials and Methods
 
Standard techniques were used for yeast manipulation (Kaiser et al.,
1994). The strains used are listed in Table I. Two-hybrid screening was
performed as described previously (James et al., 1996). An NH
 
2
 
-termi-
nally truncated (8 amino acid) form of APG1 open reading frame, sub-
cloned into pGBD-C
 
2
 
 vector, was used as bait to screen a yeast genomic li-
brary, and interacting proteins were identified by DNA sequencing. A
DNA fragment including the entire 
 
APG17
 
 gene was cloned from yeast
genomic DNA using PCR. The kinase-negative 
 
apg1
 
K54A
 
 mutation was
obtained using the QuikChange site-directed mutagenesis kit (Strat-
agene).
 
Antibody against Apg13 protein was raised against a glutathione S–trans-
ferase (GST)-Apg13 fusion protein. Specifically, a 1.9-kb BglII-XbaI
fragment of the 
 
APG13
 
 gene coding for 396 amino acids of Apg13p
was subcloned into the vector pGEX-2T. 
 
Escherichia coli
 
 strain BL21 was
transformed with the resulting plasmid. The expressed fusion protein was
purified with glutathione-Sepharose 4B (Amersham Pharmacia Biotech).
Expression and purification of the fusion protein was carried out accord-
ing to the manufacturer’s instructions. The purified fusion protein was
used to immunize a rabbit by Shibayagi.
Immunoprecipitation, kinase assay, and immunodetection of NH
 
2
 
-ter-
minally hemagglutinin (HA)-tagged Apg1 (
 
HA
 
Apg1) were performed as
described previously (Kamada et al., 1995). 
 
HA
 
Apg1 was immunoprecipi-
tated with anti-HA mAb (16B12; BabCO), and an in vitro protein kinase
assay was performed in the presence of 
 
g
 
[
 
32
 
P]ATP and myelin basic pro-
tein (MBP, substrate). The amount of immunoprecipitated 
 
HA
 
Apg1 was
monitored by immunoblot. For coimmunoprecipitation experiments,
yeast cells exponentially grown in YEPD medium were treated with zy-
molyase 100T (Seikagaku Kogyo) to generate spheroplasts. The resultant
spheroplasts were treated with or without 0.2 
 
m
 
g/ml of rapamycin and bro-
ken by resuspending in lysis buffer (PBS, pH 7.4, 1 mM EDTA, 1 mM
EGTA, 2 mM Na
 
3
 
VO
 
4
 
, 50 mM KF, 15 mM Na
 
2
 
H
 
2
 
P
 
2
 
O
 
7
 
, 15 mM P-nitrophe-
nylphosphate, 20 
 
m
 
g/ml leupeptin, 20 
 
m
 
g/ml benzamidine, 10 
 
m
 
g/ml pep-
statin A, 40 
 
m
 
g/ml aprotinin, 1 mM PMSF, and 0.5% Tween-20). Cell ly-
sate was cleared by 10-min centrifugation at 6,500 
 
g
 
 and 30-min incubation
with protein G–Sepharose (Amersham Pharmacia Biotech). 
 
HA
 
Apg1 in
the cleared cell lysate was bound to anti-HA mAb, and Apg13 was de-
tected with anti-Apg13 antibody. The resultant immunoprecipitates were
also analyzed by protein kinase assay and immunoblot with anti-HA.
For in vivo labeling of Apg13, cells (TFD13-W3) expressing 
 
APG13
 
were in vivo-labeled with 50 
 
m
 
Ci of 
 
35
 
S (Tran
 
35
 
S, ICN) for 10 min, or 50
 
m
 
Ci of 
 
32
 
Pi overnight in SD medium, and transferred to YEPD or nitro-
gen-depleted medium SD(
 
2
 
N) for 1 h. Apg13 protein was immunoprecip-
itated following TCA precipitation. Immunoprecipitated Apg13 was
treated with 5 U of alkaline phosphatase for 1 h at 30
 
8
 
C. Immunoprecipi-
tated protein was analyzed by SDS-PAGE, followed by autoradiography.
Progression of autophagy was estimated by the increase of alkaline
phosphatase activity in the cells expressing a cytosolic proform of the
phosphatase protein (pho8
 
D
 
60p; Noda et al., 1995) with 
 
a
 
-naphtyl phos-
phate as a substrate. Results were shown as means and errors calculated
from three independent experiments. Maturation of vacuole-targeted pre-
cursor API was detected by immunoblot.
 
Results
 
In an effort to study the mechanism of autophagy induc-
tion, we focused on the 
 
APG1
 
 gene, which encodes a
protein kinase whose activity is essential for autophagy
(Matsuura et al., 1997). NH
 
2
 
-terminally HA-tagged Apg1
 
Table I. Yeast Strains Used in This Study
 
Strain Genotype Source
 
KA311A
 
Mat
 
a
 
, his3 leu2 trp1 ura3
 
K. Irie (Nagoya University, Nagoya, Japan)
BJ2168
 
Mat
 
a
 
 leu2 trp1 ura3 pep4-3 prb1-1122 prc1-407
 
Y.G.S.C. (Yeast Genetic Stock Center)
TN125
 
Mat
 
a
 
 ade2 his3 leu2 lys2 trp1 ura3 pho8::pho8
 
D
 
60
 
Noda et al., 1995
CY5754
 
Mat
 
a
 
 ade2 his3 leu2 trp1 ura3 can1-100 tap42
 
D
 
::TRP1 pCEN(LEU2)[TAP42]
 
K. Arndt (Cold Spring Harbor Laboratory,
Cold Spring Harbor, NY)
CY5755
 
Mat
 
a
 
 ade2 his3 leu2 trp1 ura3 can1-100 tap42
 
D
 
::TRP1 pCEN(LEU2)[tap42-11]
 
K. Arndt
JK9-3da
 
Mat
 
a
 
 his4 leu2-3,112 trp1 ura3-52 rme1 GAL
 
1
 
 HMLa
 
M.N. Hall (University of Basel, Basel, Switzerland)
JH11-1c JK9-3da 
 
TOR1-1
 
M.N. Hall
YYK36 KA311A 
 
apg1
 
D
 
::LEU2
 
This study
YYK126 TN125 
 
apg1
 
D
 
::LEU2
 
This study
YYK130 TN125 
 
apg13
 
D
 
::TRP1
 
This study
YYK121 TN125 
 
apg17
 
D
 
::HIS3
 
This study
YYK119 KA311A 
 
apg13
 
D
 
::TRP1
 
This study
YYK111 KA311A 
 
apg17
 
D
 
::HIS3
 
This study
YYK107 KA311A 
 
cvt9
 
D
 
::URA3
 
This study
PJ69-4A
 
Mat
 
a
 
 his3-200 leu2-3,112 trp1-901 ura3-52 gal4
 
D
 
 gal80
 
D
 
 GAL2-ADE2
LYS2::GAL1-HIS3 met2::GAL7-lacZ
 
P. James (University of Wisconsin, Madison,WI) 
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(
 
HA
 
Apg1) was immunoprecipitated with anti-HA ascite
and the resultant immunocomplex was analyzed using an
in vitro kinase assay. Apg1 kinase activity was found to be
highly elevated in cells grown under starvation conditions
(Fig. 1 A). After a 6-h incubation in nitrogen-depleted me-
 
Figure 1.
 
Apg1 is activated by starvation and rapamycin treat-
ment. A, Apg1 is activated by starvation. Cells (KA311A, Cont.)
expressing HA-tagged Apg1 (
 
HA
 
Apg1, lanes 3–6) or kinase nega-
tive 
 
HA
 
Apg1
 
K54A
 
 (lanes 7–10) grown in YEPD at 30
 
8
 
C were incu-
bated in SD(
 
2
 
N) medium for 6 h. Immunoprecipitation of
 
HA
 
Apg1 from the cell lysate and protein kinase assay were car-
ried out as described in Materials and Methods (kinase assay,
top). Immunoprecipitated 
 
HA
 
Apg1 was monitored by immuno-
blot (IB, bottom). B, Apg1 activation is mediated by Tor. Wild-
type (WT, JK9-3da, lanes 1–3) or rapamycin-resistant 
 
TOR1-1
 
(JH11-1c, lanes 4 and 5) cells expressing 
 
HA
 
Apg1 grown in YEPD
were treated with or without 0.4 
 
m
 
g/ml of rapamycin for 1.5 h.
 
Apg1 kinase assay and immunodetection were performed. C, Ki-
nase activity of Apg1 is required for both the Cvt pathway and
autophagy. Wild-type (TN 125, lane 1) or 
 
apg1
 
D
 
 cells (YYK126,
lanes 2–4) transformed with wild-type 
 
APG1
 
 (WT, lane 3) or ki-
nase negative 
 
apg1
 
K54A
 
 (K54A, lane 4) plasmids were grown in
YEPD and subjected to immunoblot (IB) with anti-API antibody
(top). The precursor form of API in the cytosol (prAPI) and vac-
uolar-targeted and processed mature API (mAPI) are indicated
in the panel. Progression of autophagy was estimated by monitor-
ing the increase of alkaline phosphatase (ALP) activity (bottom).
Figure 2. Apg1-associating proteins are required for Apg1 acti-
vation. A, Wild-type (TN125, lane 1), apg1D (YYK126, lane 2),
apg13D (YYK130, lane 3), and apg17D (YYK121, lane 4) cells
were analyzed with anti-API blot (top) and ALP assay (bottom).
B, Wild-type (KA311A), apg13D (YYK119), apg17D (YYK111),
and cvt9D (YYK107) cells expressing HAApg1 were treated with
rapamycin (0.2 mg/ml, 1 h) and analyzed by kinase assay. 
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dium, SD(
 
2
 
N), the amount of activated Apg1 had appar-
ently increased, and was accompanied by slower gel migra-
tion, presumably because of autophosphorylation (Fig. 1
A, lane 6, bottom). The increase in Apg1 kinase activity is
not due to this apparent increase in the protein amount,
because shorter treatments with rapamycin (for example,
see Fig. 1 B) resulted in Apg1 activation without an in-
crease in the amount detected. Apg1 activity was also in-
creased by rapamycin treatment, but the effect of rapamy-
cin was abolished in a rapamycin resistant 
 
TOR1
 
 mutant
(
 
TOR1-1
 
; Kunz et al., 1993; Fig. 1 B). These results suggest
that Apg1 activation is required for the induction of au-
tophagy and that it is mediated by Tor proteins.
A kinase-negative 
 
apg1
 
 mutant (K54A; see Fig. 1 A)
was defective in autophagy and the Cvt pathway (Fig. 1
C). This indicates not only that the enhanced Apg1 kinase
activity is required for autophagy, but that basal Apg1 ac-
tivity in growing cells (Fig. 1 A, lane 5) is essential for the
Cvt pathway.
Next, we performed a two-hybrid screening with 
 
APG1
 
as bait to identify Apg1-associating proteins, which may
regulate Apg1 activity. The following three genes were ob-
tained from the screen: 
 
APG13
 
 (Funakoshi et al., 1997)
and two novel genes, which were subsequently found to be
essential for either autophagy or the Cvt pathway, or both.
 
Figure 3.
 
Tor-dependent phosphorylation of Apg13 inhibits
Apg1–Apg13 association. A, Bandshift of Apg13 in response to
starvation and rapamycin. YEPD-grown cells (BJ2168) express-
ing 
 
APG13
 
 with YEp352[
 
APG13
 
] (lanes 1 and 6) were trans-
ferred to SD(
 
2
 
N) medium (lanes 2–5) or treated with 0.2 
 
m
 
g/ml
rapamycin (lanes 7–10) and incubated for the indicated times.
Total protein was analyzed by immunoblot using anti-Apg13 se-
rum. B, Apg13 is hyperphosphorylated. Cells (TFD13-W3) over-
 
expressing 
 
APG13 
 
were labeled in vivo with 
 
35
 
S (lanes 1–6) or
 
32
 
Pi (lanes 7 and 8), and shifted to YEPD (lane 5) or SD(
 
2
 
N)
(lanes 6 and 8) for 1 h. Apg13 protein was immunoprecipitated
and treated with alkaline phosphatase (PPase; lane 4). Immuno-
precipitated protein was subjected to SDS-PAGE, followed by
autoradiography. Cont, immunoprecipitation was carried out
with preimmune serum. C, Tor-mediated phosphorylation/de-
phosphorylation of Apg13. Wild-type (WT, JK9-3da) or 
 
TOR1-1
 
(JH11-1c) cells expressing Apg13 grown in YEPD were treated
with or without 0.2 mg/ml of rapamycin for 1 h. An immunoblot
using anti-Apg13 serum was carried out. D, Phosphorylation/de-
phosphorylation cycle of Apg13 in response to nutrient condi-
tions. YEPD-grown cells (BJ2168) overexpressing Apg13 (lane
1) were incubated in SD(2N) for 1.5 h (lane 2) with or without
30-min treatment with 10 mg/ml cycloheximide (lanes 4 and 5),
0.2 mg/ml of rapamycin (lanes 6 and 7), or both (lanes 8 and 9).
Then, half a sample volume of 23 YEPD was added to the cells,
after which they were incubated for 10 min (lanes 3, 5, 7, and 9).
Apg13 protein was detected by immunoblot. E, Coimmunopre-
cipitation of Apg13 with Apg1. YEPD grown cells (BJ2168)
overexpressing HAApg1 and/or Apg13 with high-copy plas-
mids  pRS426[HAAPG1] (p[HAAPG1]) and YEp351[APG13]
(p[APG13]) were lysed, and HAApg1 was immunoprecipitated
(IP) from the cell lysate. Apg13 and HAApg1 were detected by
immunoblot (lanes 1–6). Apg13 and HAApg1 detected in total cell
lysate are also shown (lanes 7–9). The hyperphosphorylated form
of Apg13 remaining in the supernatant of the immunoprecipitate
was still detected (data not shown), excluding the possibility that
Apg1-bound Apg13 was dephosphorylated during the experi-
ment. The asterisk shows a band that anti-HA ascite nonspecifi-
cally recognized in total lysate. F, Apg1–Apg13 association is
promoted by rapamycin treatment. YEPD-grown cells (BJ2168)
expressing  HAApg1 and Apg13 with low-copy plasmids
pRS316[HAAPG1] and pRS315[APG13] were enzymatically con-
verted to spheroplasts and treated with 0.2 mg/ml of rapamycin
(at time 0). Spheroplasts were harvested at the indicated times,
and coimmunoprecipitation was performed. Apg1 protein kinase
assay of the immunoprecipitates was also performed (bottom).Kamada et al. Apg1 Complex Regulates Autophagy 1511
One gene, designated as APG17 (YLR423c), was essential
for only autophagy and was not required for the Cvt path-
way (Fig. 2 A). The other, CVT9 (Harding et al., 1996; D.J.
Klionsky, personal communication), was required for the
Cvt pathway, but not for autophagy. Among the 16 APG
genes discovered so far, APG17 is the first one identified
whose function is restricted to autophagy. It is interesting
to note that Apg1 binds to proteins whose function is spe-
cific to either autophagy (Apg17) or the Cvt pathway
(Cvt9). Overexpression of APG1 in an apg13D mutant
partially rescues the autophagy defect (Funakoshi et al.,
1997). Similarly, the apg17D mutant was also rescued by
overexpression of APG1 (data not shown), indicating that
these three genes interact functionally. We tested whether
these Apg1-associated proteins are involved in Apg1 acti-
vation. As shown in Fig. 2 B, deletion of each gene af-
fected Apg1 activation by rapamycin treatment. In the
apg13D mutant, attenuated Apg1 activity was observed. In
rapamycin-treated  apg17D cells, Apg1 activity also was
found to be largely impaired (z20% of the wild-type). On
the other hand, deletion of CVT9, which is not needed for
autophagy, resulted in rapamycin-induced activation of
Apg1 to 50% of wild-type. The effects of deleting APG13
and APG17 on Apg1 activity are not the result of a gen-
eral autophagy defect, because deletion of other APG
genes, such as APG5 (Mizushima et al., 1998), does not af-
fect the activation of Apg1 (data not shown). These results
indicate that the activated state of Apg1 is required for au-
tophagy induction, and that Apg13 and Apg17 play a key
role in the activation of Apg1 in response to Tor inhibi-
tion.
The next question we addressed was how these Apg1-
associating proteins transmit the starvation signal from
Tor to Apg1. To this end, the biochemical character of
the Apg13 protein was investigated. Overexpression of
APG13 resulted in a smeared Apg13 band on the immu-
noblot caused by retarded migration, indicating that it was
modified in some way (Fig. 3 A). This modified form was
observed only in growing cells, and after starvation or
rapamycin treatment, the slower-migrating form disap-
peared. In particular, it was noted that the disappearance
of the slower-migrating form occurred within five minutes
after rapamycin treatment. In vivo labeling and in vitro
phosphatase treatment revealed that the Apg13 bandshift
was due to phosphorylation (Fig. 3 B). These results sug-
gest that Apg13 is phosphorylated in a Tor-dependent
manner, which was confirmed by the observation that
dephosphorylation of Apg13 in response to rapamycin was
not seen in TOR1-1 cells (Fig. 3 C). The dephosphory-
lated, faster-migrating form of Apg13 in starved cells was
rapidly phosphorylated after readdition of YEPD medium
(Fig. 3 D), suggesting that the phosphorylation state of
Apg13 is extremely sensitive to nutrient conditions. This
rephosphorylation is attenuated significantly by rapamy-
cin, but is not affected by cycloheximide. This excludes the
possibility that the phosphorylated form of Apg13 is de-
graded upon starvation and Apg13 is de novo synthesized
after medium addition. The faster-migrating form of
Apg13 (as well as the slower-migrating form) was found to
be labeled with 32Pi (Fig. 3 B, lane 8), suggesting that
Apg13 remains partially phosphorylated under starvation
conditions.
To confirm that there is a physical association between
Apg1 and Apg13, we carried out a coimmunoprecipitation
experiment. A vacuolar protease-deficient strain was used
for these experiments because Apg13 is quite labile in cell
lysate. When HAAPG1 and APG13 were expressed from a
Figure 4. Apg1–Apg13 association is required for autophagy, but
not for the Cvt pathway. A, Apg1-binding site of Apg13. Interac-
tion of the indicated Apg13 fragments (prey) with Apg1 (bait) in
the yeast two-hybrid system. Binding activity was estimated by
b-galactosidase activity (Kaiser et al., 1994, shown as means and
errors calculated from three independent experiments). B,
Apg1–Apg13 association is required specifically for autophagy.
Wild-type cells (TN125) or apg13D cells (YYK130) harboring the
indicated APG13 constructs grown in YEPD were analyzed by
anti-API immunoblot (top). An ALP assay was performed after
4 h SD(2N) incubation (bottom). C, Apg1 kinase assay was per-
formed using the above APG13 transformants before or after ra-
pamycin (0.2 mg/ml, 1 h) treatment.The Journal of Cell Biology, Volume 150, 2000 1512
high-copy plasmid, only the faster-migrating form of Apg13
was detected in the Apg1 immunocomplex (Fig. 3 E), indi-
cating that the hyperphosphorylated form of Apg13 has
little affinity for Apg1. Next, we performed the experi-
ment using a low-copy plasmid to more closely approxi-
mate physiological cellular conditions. The amount of
Apg13 bound to Apg1 increased rapidly (as quickly as 10
min) after rapamycin treatment (Fig. 3 F), which cor-
responds well to the time course of Apg13 dephosphory-
lation. Apg1 activation was also observed to be tightly
linked with this Apg1–Apg13 association. These results
strongly indicate that Tor negatively regulates Apg1 ki-
nase activity by means of (hyper)phosphorylation of
Apg13, which reduces the affinity of Apg13 for Apg1.
From these results, we hypothesized that Apg13 binding
to Apg1 is required for the induction of autophagy, but
not for the Cvt pathway. Therefore, we examined autoph-
agy using apg13 mutants. The two-hybrid assay was used
to determine the Apg1-binding site on Apg13, using vari-
ous APG13 open reading frame fragments as prey. A cen-
tral 89-amino acid region (432–520) was found to be re-
sponsible for Apg1 binding (Fig. 4 A). We also isolated a
COOH-terminal truncated form of Apg13, Apg13(1–448),
whose Ser449 was mutated to a stop codon using in vitro
mutagenesis (Kaiser et al., 1994). This mutant has a muta-
tion within the putative Apg1-binding site, and is unable to
associate with Apg1, as confirmed by the two-hybrid assay
and coimmunoprecipitation (Fig. 4 A, and data not
shown). This result indicates a role for a domain of Apg13
around amino acid 448 in binding Apg1. We tested sev-
eral COOH-terminal truncated Apg13 mutants including
Apg13(1–448) for autophagy activity. Apg13(1–448) did
not rescue the autophagic defect at all (Fig. 4 B, bottom),
presumably due to the absence of the Apg1-binding do-
main. Another COOH-terminal truncated form, Apg13
(1–568), which contains the entire putative Apg1-binding
domain, displayed partial, but significant, autophagic ac-
tivity, when compared with Apg13(1–448). Apg13(1–568)
was less competent for autophagic import than full-length
Apg13, suggesting that additional sequences downstream
of the Apg1 binding site are important for maximal activ-
ity. On the other hand, Apg13(1–448) partially, but signifi-
cantly, rescued vacuolar-targeting of precursor API (Fig. 4
B, top), suggesting that this truncated protein is still func-
tional for the Cvt pathway. Apg1 activity in the apg13D
mutant was partially restored in the presence of either
Apg13(1–448) or Apg13(1–568), and was fully recovered
in the presence of the whole APG13 construct (Fig. 4 C).
The kinase activity of the Apg13(1–568) transformant was
clearly higher than that of the Apg13(1–448) transformant.
These results confirmed the hypothesis that the Apg1–
Apg13 association and subsequent activation of Apg1 are
required for autophagy induction in response to starva-
tion.
It is currently thought that Tor signaling in yeast is bifur-
cated (Thomas and Hall, 1997). One pathway involves the
small GTPase Rho1, which is responsible for actin organi-
zation and is not affected by rapamycin. The other in-
volves Tap42, a rapamycin-sensitive phosphatase-associat-
ing protein that is necessary for the initiation of protein
translation and amino acid permease turnover (Di Como
and Arndt, 1996). TAP42 is known to be located directly
downstream of Tor, and is required for Tor-mediated sig-
naling, especially the rapamycin-sensitive branch (Jiang
and Broach, 1999). To investigate this issue further, we
tested the ability of a tap42ts mutant (tap42-11; Di Como
and Arndt, 1996) to induce autophagy at a nonpermissive
temperature. This mutation was previously found to con-
fer rapamycin resistance at permissive temperatures. Ac-
cumulation of vacuolar autophagic bodies in tap42 cells
was found to be comparable to that in wild-type cells, con-
firming that induction of autophagy is not controlled by
Tap42 (Fig. 5). Furthermore, deletion of NPR1, whose
product is a protein kinase negatively regulated by Tap42
(Schmidt et al., 1998), did not affect the induction of au-
tophagy (data not shown). Therefore, we concluded that
Tap42 does not transmit a signal from Tor in the autoph-
agy induction pathway.
Discussion
We have shown that Apg1 forms complexes with Apg13,
Apg17, and Cvt9. The association between Apg1 and
Figure 5. Tap42 does not mediate the induction of autophagy.
Autophagy is normal in tap42ts cells. Wild-type (CY5754) and
tap42-11ts (CY5755) cells were incubated for 4 h at the indicated
temperature with or without rapamycin (0.2 mg/ml) in the pres-
ence of 1 mM PMSF to visualize autophagic bodies. For incuba-
tion at the nonpermissive temperature, 1 h preincubation was
carried out. DIC images were shown. Bar, 2 mm.
Figure 6. Model of Tor-mediated regulation between the Cvt
pathway and autophagy. See text for details.Kamada et al. Apg1 Complex Regulates Autophagy 1513
Apg13 is negatively regulated by Tor signaling. In nutri-
ent-rich conditions, active Tor causes hyperphosphoryla-
tion of Apg13, which prevents its association with Apg1.
Starvation or rapamycin treatment represses Tor activity,
and Apg13 is immediately dephosphorylated. Dephosphor-
ylated Apg13 possesses a high affinity for Apg1, which is
activated upon Apg13 binding, leading to induction of au-
tophagy. This tight Apg1–Apg13 association is required
for autophagy, but not for the Cvt pathway, an observa-
tion that supports a model in which the Apg1–Apg13 com-
plex plays an important role in switching from the Cvt
pathway to autophagy in response to nutrient conditions
(Fig. 6). The phenotypes of apg17D and cvt9D cells lend
further support to this idea. The function of Apg17 is still
unclear, but our preliminary results suggest that it may be
involved in the Apg1–Apg13 interaction. When both
Apg1 and Apg13 were overexpressed, Apg1–Apg13 bind-
ing was observed, even in cells grown in YEPD (Fig. 3 D),
resulting in a small amount of Apg1 activation, insufficient
to induce autophagy (e.g., see Fig. 4 C, lanes 1 and 10).
Presumably, additional factors such as Apg17 are needed
for full activation of Apg1.
Protein sorting to the plasma membrane and vacuolar
degradation of amino acid permeases, Gap1 and Tat2, are
also regulated in response to nutrient conditions, and are
dependent upon Tor, Npr1, and Tap42 (but not on Apg1;
Roberg et al., 1997; Beck et al., 1999). Tap42 plays a key
role in the rapamycin-sensitive Tor pathway, suppressing
Npr1 activity (Schmidt et al., 1998). Our observation that
Tor regulation of Apg1 activity and autophagy induction is
rapamycin-sensitive, but Tap42-independent, implies that
the Apg1–Apg13 interplay comprises a novel Tor signal-
ing pathway regulating autophagy induction. It is possible
that Tor directly phosphorylates Apg13, but this remains
to be investigated. Recently, nuclear transport of tran-
scription factor Gln3 has been shown to be under the con-
trol of Tor signaling, but the involvement of Tap42 in this
system is still controversial (Beck and Hall, 1999; Carde-
nas et al., 1999). Deletion of GLN3 did not affected au-
tophagy (data not shown). In mammalian cells, two targets
of mammalian Tor (mTOR) have been identified: 4E-BP1
and p70S6K (Thomas and Hall, 1997). Another recent
study reported a relationship between mammalian Tor
and autophagy (Shigemitsu et al., 1999). APG1 homo-
logues of Caenorhabditis elegans (Ogura et al., 1994) and
mammals (Yan et al., 1998) have also been reported, sug-
gesting that the Tor–Apg1 pathway might be conserved in
eukaryotic cells.
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